NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹227 Cr | ₹216 Cr | ₹311 Cr | ₹340 Cr | ₹351 Cr |
What is the latest Net Current Assets ratio of NECTAR LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹227 Cr |
| Mar2025 | ₹216 Cr |
| Mar2024 | ₹311 Cr |
| Mar2023 | ₹340 Cr |
| Mar2022 | ₹351 Cr |
How is Net Current Assets of NECTAR LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹227 Cr | 5.03 | |
| Mar2025 | ₹216 Cr | -30.54 | |
| Mar2024 | ₹311 Cr | -8.59 | |
| Mar2023 | ₹340 Cr | -3.07 | |
| Mar2022 | ₹351 Cr | - | |
Compare Net Current Assets of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹214.3 Cr | 3% | -9.2% | -28.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 3% |
-9.2% |
-28.1% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses